Form D · Biotechnology
EpigenCare Inc.
Farmingdale, NY · CIK 0001727821
Offering snapshot reported Apr 12, 2018 · SEC filing
- Reported sold
- Yet to sell Offering amount: $20M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $200 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Minimum accepted$100 → $200
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 12, 2018 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Jan 16, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jan 16, 2018 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-303276
Digital Token Security with Conversion-to-Equity Rights
Source: Form D, filed Apr 12, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Lee | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
110 Bi County Blvd Ste 122
Farmingdale, NY, 11735
Farmingdale, NY, 11735